Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma

Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma

Abstract Background This phase I study aimed to assess the safety, dose‐limiting toxicity (DLT), maximum tolerated dose (MTD) and preliminary effect of nanoparticle albumin‐bound (nab)‐paclitaxel in combination with concurrent chemoradiotherapy in patients with locally advanced esophageal squamous c...

Full description

Bibliographic Details
Main Authors:	Hui Jiang, Qiaoqiao Li, Baoqing Chen, Mian Xi, Kanjiebubi Makelike, Shiliang Liu, Yonghong Hu, Yujia Zhu
Format:	Article
Language:	English
Published:	Wiley 2023-07-01
Series:	Cancer Medicine
Subjects:	dose escalation esophageal squamous cell carcinoma nanoparticle albumin‐bound‐paclitaxel phase I study radiotherapy
Online Access:	https://doi.org/10.1002/cam4.6205

Similar Items

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
by: Hui Jiang, et al.
Published: (2023-09-01)

The efficacy and safety of nanoparticle albumin bound‐paclitaxel‐based regimen as second‐ or third‐line treatment in patients with advanced esophageal squamous cell carcinoma
by: Dao Xin, et al.
Published: (2023-05-01)

Evaluate the Clinical Outcome of Nanoparticle Albumin-bound Paclitaxel on Breast Cancer Treatment: A Systematic Review and Meta-analysis
by: Yasaman Shariati, et al.
Published: (2022-09-01)

A case report of hypocalcemia after chemotherapy with albumin‐bound paclitaxel
by: Zhongchao Wang, et al.
Published: (2023-03-01)

Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes
by: Sei-ichiro Motegi, et al.
Published: (2019-10-01)

Efficacy and safety of albumin-bound paclitaxel combined with gemcitabine in the treatment of advanced and metastatic pancreatic cancer
by: TIAN Yue, et al.
Published: (2023-09-01)

Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trialResearch in context
by: Yin Wang, et al.
Published: (2023-11-01)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer
by: Hiroaki Yamane, et al.
Published: (2023-10-01)

Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
by: Shanqiang Qu, et al.
Published: (2023-10-01)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
by: Yafan Yang, et al.
Published: (2023-03-01)

Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis
by: Qiong Yi, et al.
Published: (2023-03-01)

Evaluation of nanoparticle albumin-bound paclitaxel loaded macrophages for glioblastoma treatment based on a microfluidic chip
by: Zuorun Xie, et al.
Published: (2024-03-01)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
by: Jingjing Zhang, et al.
Published: (2023-03-01)

The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients
by: Leni van Doorn, et al.
Published: (2021-01-01)

Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer
by: Eelke L.A. Toxopeus, et al.
Published: (2019-02-01)

Comparison of survival and adverse effect profile in patients with esophageal cancer treated with the combination of carboplatin and paclitaxel vs. 5-flourouracil and cisplatin
by: N. Nisar, et al.
Published: (2022-09-01)

Macular Cystoid Edema Induced by Nab-Paclitaxel
by: Sara Alves Pereira, et al.
Published: (2022-04-01)

MRI-guided microwave ablation and albumin-bound paclitaxel for lung tumors: Initial experience
by: Xiaokang Shen, et al.
Published: (2022-11-01)

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
by: Li Jiang, et al.
Published: (2022-12-01)

Efficacy and safety of camrelizumab combined with albumin-bound paclitaxel as third- or later-line regimen in patients with advanced non-small cell lung cancer
by: Jianfeng Zhu, et al.
Published: (2023-12-01)

PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis
by: Jia Zhao, et al.
Published: (2023-12-01)

Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein
by: Wenwen Xu, et al.
Published: (2023-11-01)

Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis
by: Marko Damm, et al.
Published: (2021-08-01)

A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma
by: Ning Li, et al.
Published: (2022-12-01)

Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma
by: Julian Mangesius, et al.
Published: (2023-07-01)

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study
by: Zhichao Tian, et al.
Published: (2022-01-01)

Paclitaxel promotes mTOR signaling‐mediated apoptosis in esophageal cancer cells by targeting MUC20
by: Meng Li, et al.
Published: (2023-11-01)

Efficacy and safety of nanoparticle albumin-bound paclitaxel in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials and observational studies
by: Nittiya Suwannasom, et al.
Published: (2023-11-01)

Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study
by: Xing Gao, et al.
Published: (2022-05-01)

Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer
by: Shiori Sadaka, et al.
Published: (2022-10-01)

A prospective comparative study of concurrent chemoradiation in advanced carcinoma cervix patients with weekly cisplatin vs. weekly cisplatin and paclitaxel
by: Amit K Mukherjee, et al.
Published: (2022-01-01)

Albumin-bound paclitaxel in the treatment of metastatic breast cancer
by: E V Artamonova
Published: (2017-01-01)

Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)
by: Nan Zhou, et al.
Published: (2023-08-01)

A Meta-Analysis and Review of Radiation Dose Escalation in Definitive Radiation Therapy between Squamous Cell Carcinoma and Adenocarcinoma of Esophageal Cancer
by: Yu Liou, et al.
Published: (2024-02-01)

Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy
by: Akmal M. Asrorov, et al.
Published: (2024-06-01)

Study to evaluate the acute toxicities and response to concurrent chemoradiotherapy with weekly cisplatin versus cisplatin and paclitaxel in locally advanced head-and-neck cancer
by: Tony Jacob, et al.
Published: (2023-01-01)

Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer
by: Tiantian Tan, et al.
Published: (2023-07-01)

Research and Application of Kupffer Cell Thresholds for BSA Nanoparticles
by: Huanhuan Guo, et al.
Published: (2023-01-01)

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study
by: I. A. Pokataev, et al.
Published: (2019-12-01)